Search results
Roche’s Sabry retires; Duchenne drug fails confirmatory test
BioPharma Dive via Yahoo Finance· 3 weeks agoThe veteran executive will be replaced by Boris Zaïtra. Elsewhere, Nippon Shinyaku shared negative...
NS Pharma reports data from Phase III Duchenne treatment trial
Clinical Trials Arena via Yahoo Finance· 3 weeks agoNS Pharma, a subsidiary of Japanese pharmaceutical company Nippon Shinyaku, has announced...
Capricor Therapeutics Inc (CAPR) Reports Encouraging Year-End Financials and Advances in DMD Therapy
GuruFocus.com via Yahoo Finance· 4 months agoRevenue Growth: Q4 revenue soared to $12.1 million, a significant increase from $1.0 million in Q4...
Unveiling 3 Top Japanese Dividend Stocks With Yields Up To 4.4%
Simply Wall St. via Yahoo Finance· 2 weeks agoAmidst a backdrop of mixed weekly returns in the Japanese stock markets and ongoing speculation...
Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoCapricor Therapeutics, Inc. (NASDAQ:CAPR) Q4 2022 Earnings Call Transcript March 15, 2023 Operator:...
Capricor Therapeutics Inc (CAPR) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
GuruFocus.com via Yahoo Finance· 1 month agoCash Position: As of March 31, 2024, totaled approximately $39.9 million. Revenue: Received a $10 million milestone payment from Nippon Shinyaku in Q1 2024. Research and Development Expenses ...
Pfizer setback brings questions for Duchenne gene therapy ahead of Sarepta decision
BioPharma Dive via Yahoo Finance· 3 days agoThe failure of another trial adds to uncertainty around the benefits of the gene-based treatments,...
2 “Strong Buy” Penny Stocks That Could Rally All the Way to $15
TipRanks via Yahoo Finance· 2 years agoWhich stocks are either a fan favorite or a must-avoid? Penny stocks. These tickers going for less...
Q4 2023 Capricor Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 4 months agoParticipants Anthony Bergmann; Chief Financial Officer; Capricor Therapeutics Inc Linda Marbán; Chief Executive Officer and Director; Capricor Therapeutics Inc Joseph Pantginis; Analyst; H.C ...